Clinical Trials Directory

Trials / Unknown

UnknownNCT04318067

Melatonin in ADHD and Sleep Problems

Melatonin - Production and Release in Children and Adolescents With ADHD and Chronic Sleep Problems and Effects of Melatonin on Sleep

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Allan Hvolby · Academic / Other
Sex
All
Age
6 Years – 13 Years
Healthy volunteers
Not accepted

Summary

Treatment with melatonin is often initiated on an insufficient basis as it has not been established prior to starting the treatment whether or not the child had delayed release of endogenous melatonin. At the clinic, it has furthermore been observed that the length of time a child experiences an effect of melatonin treatment varies substantially. In a clinical context, treatment with melatonin is used increasingly (www.Medstat.dk). However, there is no tradition in Denmark for measuring the endogenous melatonin level before initiating such treatment. Hence there is no way of knowing to what extent the sleep problems were indeed caused by delayed melatonin release. There seem to be no studies on the difference in the effect of melatonin treatment of children and adolescents depending on whether or not they have delayed DLMO. Likewise, there are no studies including adolescents. As can be seen, it is important to gain more knowledge about the normal release of melatonin, and the release of melatonin in a group of children and adolescents with a variety of psychiatric diagnoses. It is also essential to investigate whether there are any differences in the release of melatonin in children and adolescents with chronic sleep onset problem and children and adolescents who do not have sleep problems.

Conditions

Interventions

TypeNameDescription
DRUGMelatonin 3 mgMelatonin 3 mg is given ones a day - at bedtimes for 6 month

Timeline

Start date
2020-09-01
Primary completion
2024-04-01
Completion
2024-11-01
First posted
2020-03-23
Last updated
2022-05-09

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04318067. Inclusion in this directory is not an endorsement.